Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119393743 | 11939374 | 3 | F | 20160628 | 20160122 | 20160706 | EXP | JP-PFIZER INC-2016027636 | PFIZER | SAITO, A.. BENEFICIAL EFFECTS OF SILDENAFIL ON CYANOTIC CONDITION IN A PATIENT WITH REPAIRED DOUBLE OUTLET RIGHT VENTRICLE, R-L SHUNT, AND RESIDUAL PULMONARY HYPERTENSION. JOURNAL OF ADULT CONGENITAL HEART DISEASE. 2016;102 | 43.00 | YR | F | Y | 0.00000 | 20160706 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119393743 | 11939374 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 60 MG, DAILY | Y | 21845 | 60 | MG | FILM-COATED TABLET | ||||||
119393743 | 11939374 | 2 | C | BOSENTAN. | BOSENTAN | 1 | Oral | UNK | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119393743 | 11939374 | 1 | Pulmonary hypertension |
119393743 | 11939374 | 2 | Pulmonary hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119393743 | 11939374 | OT |
119393743 | 11939374 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119393743 | 11939374 | Cardiac valve disease | |
119393743 | 11939374 | Condition aggravated | |
119393743 | 11939374 | Right ventricular failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |